AZD8848
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Butyrylcholinesterase Deficiency
Conditions
Butyrylcholinesterase Deficiency
Trial Timeline
Sep 1, 2010 → Jan 1, 2012
NCT ID
NCT01205867About AZD8848
AZD8848 is a phase 1 stage product being developed by AstraZeneca for Butyrylcholinesterase Deficiency. The current trial status is completed. This product is registered under clinical trial identifier NCT01205867. Target conditions include Butyrylcholinesterase Deficiency.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01205867 | Phase 1 | Completed |